In line with this notion are earlier findings from Kim et al. in cancer cells, demonstrating that the CXCL12/CXCR4 axis is involved in SREBP-1-mediated FASN expression by enhancing the nuclear translocation of SREBP-192. Here, CXCL12 is linked to cancer.